
CAS Name: Dihydroxyphosphinecarboxylic acid oxide trisodium salt
Additional Names: trisodium phosphonoformate; trisodium carboxyphosphateTrademarks: Foscavir (AstraZeneca)
Percent Compositio...
Literature References: Inhibits viral DNA polymerase and reverse transcriptase. Prepn: P. Nylén, Ber. 57B, 1023 (1924). Crystal structure: R. R. Naqvi et al., J. Chem. Soc. A 1971, 2751; S. C. Abrahams, Acta Crystallogr. B28, 2886 (1972). Use as antiviral agent: B. F. H. Eriksson et al., DE 2728685; eidem, US 4215113 (1978, 1980 both to Astra). Activity against herpes simplex virus: E. Helgstrand et al., Science 201, 819 (1978); J. M. Reno et al., Antimicrob. Agents Chemother. 13, 188 (1978); S. Alenius et al., Arch. Virol. 60, 197 (1979). Mechanism of inhibition of Epstein-Barr virus replication: A. K. Datta, R. E. Hood, Virology 114, 52 (1981). Preclinical evaluation: B. Oeberg et al., Int. Congr. Ser. - Excerpta Med. 571, 175 (1982). Inhibitory effect on HIV-1 (HTLV-III/LAV) virus replication in vitro: P. S. Sarin et al., Biochem. Pharmacol. 34, 4075 (1985).
CAS Name: N,N-Diethylglycine 4-(acetylamino)phenyl ester
Additional Names: N,N-diethylglycine ester with 4'-hydroxyacetanilide; 4-acetamidophenyl (diethylamino)acetate
Percent Composition: C...
Literature References: Injectable prodrug of acetaminophen, q.v. Prepn and pharmacology: J. C. Cognacq, BE 854376; idem, US 4127671 (1977, 1978 both to Hexachimie). Clinical comparison with injectable aspirin: R. De Marneffe, L. Mokassa, C. R. Ther. Pharmacol. Clin. 3, 23 (1985). Clinical studies: P. Delacroix et al., Sem. Hop. 61, 2739 (1985); J. Modai, ibid. 62, 587 (1986).
CAS Name: N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]propanamide
Percent Composition: C 61.61%, H 4.90%, N 7.56%, O 17.28%, S 8.66%
Literature References: Injectable prodrug of valdecoxib, q.v., a selective cyclooxygenase-2 (COX-2) inhibitor. Prepn: J. J. Talley et al., WO 9738986; eidem, US 5932598 (1997, 1999 both to Searle); eidem, J. Med. Chem. 43, 1661 (2000). Clinical pharmacokinetics: A. Karim et al., J. Clin. Pharmacol. 41, 1111 (2001). Pharmacological profile: S. S. V. Padi et al., Eur. J. Pharmacol. 491, 69 (2004). Clinical evaluation in post-surgical pain: N. A. Nussmeier et al., Anesthesiology 104, 518 (2006). Comparison of GI effects with ketorolac: R. R. Stoltz et al., Am. J. Gastroenterol. 97, 65 (2002). Review of pharmacology and clinical experience: S. M. Cheer, K. L. Goa, Drugs 61, 1133-1141 (2001).
CAS Name: (6R,7R)-7-[[(2Z)-(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Additional Names: (6R,7R)-7-[2-(2-imino-4-thiazolyl)glyox...
Literature References: Injectable third generation cephalosporin antibiotic related to cefotaxime, q.v. Exhibits broad spectrum activity and resistance to b-lactamase hydrolysis. Prepn: T. Takaya et al., DE 2810922; eidem, US 4427674 (1978, 1984 both to Fujisawa). In vitro and in vivo antibacterial activity: T. Kamimura et al., Antimicrob. Agents Chemother. 16, 540 (1979). Comparison with other cephalosporins: M. Nishida et al., J. Antibiot. 32, 1319 (1979). Pharmacokinetics: T. Murakawa et al., Antimicrob. Agents Chemother. 17, 157 (1980). Series of articles on metabolism, pharmacology, laboratory evaluation: Arzneim.-Forsch. 30, 1662-1687 (1980). Toxicity and reproduction studies: K. Fukuhara et al., ibid. 1669. Phase I clinical study: N. Nakashima et al., J. Clin. Pharmacol. 21, 388 (1981). Reviews: J. Antimicrob. Chemother. 10, Suppl. C, 1-355 (1982); D. M. Richards, R. C. Heel, Drugs 29, 281-329 (1985).
CAS Name: (6R,7R)-7-[[[2-(Aminomethyl)phenyl]acetyl]amino]-3-[[[1-(carboxymethyl)-1H-tetrazol-5-yl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Additional Names: (6R...
Literature References: Injectable, semi-synthetic cephalosporin antibiotic. Prepn: M. A. Kaplan et al., DE 2538804; W. J. Gottstein et al., US 4100346, US 4172196 and US 4182863 (1976, 1978, 1979, 1980 all to Bristol-Myers); W. J. Gottstein et al., J. Antibiot. 29, 1226 (1976). Laboratory evaluation: F. Leitner et al., Antimicrob. Agents Chemother. 10, 426 (1976). In vitro susceptibility comparisons: R. N. Jones et al., J. Antibiot. 30, 576, 583 (1977). Comparative tissue distribution: F. H. Lee et al., Antimicrob. Agents Chemother. 19, 625 (1981). Pharmacokinetics: E. H. Estey et al., Clin. Pharmacol. Ther. 30, 396 (1981); S. S. Hawkins et al., ibid. 468. Clinical study: R. J. Wallace et al., Antimicrob. Agents Chemother. 20, 648 (1981).
CAS Name: 1,2-Dihydro-5-imidazo[1,2-a]pyridin-6-yl-6-methyl-2-oxo-3-pyridinecarbonitrile
Additional Names: 1,2-dihydro-5-imidazo[1,2-a]pyridin-6-yl-6-methyl-2-oxonicotinonitrile; olprinone
P...
Literature References: Inotropic agent which inhibits cAMP phosphodiesterase. Prepn: M. Yamanaka et al., JP Kokai 86 218589; eidem, US 4751227 (1986, 1988 both to Eisai). Synthesis: M. Yamanaka et al., J. Labelled Compd. Radiopharm. 31, 125 (1992). Pharmacology: M. Tajimi et al., Arch. Pharmacol. 344, 602 (1991). Pharmacokinetics in dogs: Y. Uemura et al., J. Pharm. Pharmacol. 45, 1077 (1993). Review of pharmacology, toxicology and clinical evaluation: M. Endoh, Cardiovasc. Drug Rev. 11, 432-450 (1993).
CAS Name: 2-Methylpropanoic acid 4-[2-(methylamino)ethyl]-1,2-phenylene ester
Additional Names: 4-[2-(methylamino)ethyl]-o-phenylene diisobutyrate; N-methyldopamine diisobutyric ester; 3,4-di-o...
Literature References: Inotropic agent with dopaminergic and adrenergic agonist activities; converted to active metabolite, deoxyepinephrine, q.v. Prepn: C. Casagrande, G. Ferrari, DE 2734678; eidem, US 4218470 (1978, 1980 both to Simes). Pharmacology: G. F. Melloni et al., Curr. Ther. Res. 25, 406 (1979); eidem, ibid. 26, 466 (1979). Series of articles on synthesis, pharmacology, clinical efficacy: Arzneim.-Forsch. 36, 285-408 (1986). Review of pharmacodynamics, pharmacokinetics and therapeutic efficacy: J. M. Henwood, P. A. Todd, Drugs 36, 11-31 (1988). Series of articles on clinical use in congestive heart failure: Cardiology 77, Suppl. 5, 1-95 (1990). Clinical efficacy and safety in heart failure: J. R. Hampton et al., Lancet 349, 971 (1997). Clinical evaluation in diagnosis of glaucoma: G. Marchini et al., J. Ocul. Pharmacol. Ther. 17, 215 (2001); in treatment of ocular hypertony: L. C. Ugahary et al., Am. J. Ophthalmol. 141, 571 (2006).
CAS Name: N-Cyclopropyl-1,3,5-triazine-2,4,6-triamine
Additional Names: 2-cyclopropylamino-4,6-diamino-s-triazineTrademarks: Larvadex (Novartis); Neporex (Novartis); Trigard (Syngenta); Vetrazi...
Literature References: Insect growth regulator. Prepn: H. U. Brechbuhler et al., DE 2736876; eidem, US 4225598 (1978, 1980 to Ciba-Geigy). Activity: R. D. Hall, M. C. Foehse, J. Econ. Entomol. 73, 564 (1980); R. J. Hart et al., Aust. Vet. J. 59, 104 (1982).
CAS Name: [15(3aS,7R)]-3,4-Didehydro-19-hydroxy-16,17-dimethoxy-1-methyl-15-(2,3,5,6-tetrahydro-11-hydroxy-4-methyl-1,13-dioxo-1H-3a,7-methanopyrrolo[1,2-a][1,3]benzodiazocin-7(4H)-yl)aspidospermi...
Literature References: Insecticidal alkaloid from the Mexican plant Haplophyton cimicidum A. DC., Apocynaceae: Rogers et al., J. Am. Chem. Soc. 74, 1987 (1952); 76, 2819 (1954). Partial structure: Snyder et al., ibid. 80, 3708 (1958). Structure: Rae et al., ibid. 89, 3061 (1967). Crystal structure and absolute config.: Zacharias, Acta Crystallogr. 26B, 1455 (1970). Synthetic approaches: P. Yates, D. A. Schwartz, Can. J. Chem. 61, 509 (1983). Review: Yates et al., J. Am. Chem. Soc. 95, 7842 (1973).
CAS Name: (2E,6Z,8E)-N-(2-Methylpropyl)-2,6,8-decatrienamide
Additional Names: (E,E,Z)-N-isobutyl-2,6,8-decatrienamide; N-isobutyldeca-trans-2-cis-6-trans-8-trienamide; spilanthol
Percent Co...
Literature References: Insecticidal lipid amide isolated from Heliopsis longipes (A. Gray) Blake, Compositae. Isoln and structure: Acree et al., J. Org. Chem. 10, 236, 449 (1945). Identity with spilanthol: Jacobson, Chem. Ind. (London) 1957, 50. Stereochemistry and synthesis: Crombie, Krasinski, ibid. 1962, 983; Crombie et al., J. Chem. Soc. 1963, 4970.
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
